Live tape
Top 8, mentions 7d15,603MSFT3,079 mentions▲ +0.09GOOGL2,153 mentions▲ +0.05AAPL2,110 mentions▲ +0.07META2,079 mentions▲ +0.04SNDK1,825 mentions▲ +0.06NVDA1,592 mentions▲ +0.07SPCX1,543 mentions▲ +0.06QQQ1,222 mentions▲ +0.04

Equity · Healthcare

ATR

AptarGroup, Inc. · NYSE

$138.00 +3.45% 1D Finazon · prior-day close · Jul 28, 2026
Price · Chart Chart by TradingView

The chart above plots the price of ATR over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 62 sessions over that window: $121.00 on 4 May 2026 through $138.00 on 28 July 2026. Finazon · prior-day close.

Market cap $8.8B
P/E (TTM) 23.5
52-week range $111.96 – $162.00
Avg volume 112.3K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Jul 29, 2026

ATR insider trades

SEC Form 4 · last 90 days · newest reported trade 16 Jul 2026
Open-market buys 0
Open-market sells 4
Net sold $1.62M
Non-trade filings 21
Date Insider Type Shares Value
09 Jun 2026 Prieur Marc Segment President Sell 5,000 $578K
04 Jun 2026 Vinczeller Shiela Chief Human Resources Officer Sell 3,555 $400K

Showing the 12 most recent of 25 filings in this window. The figures above count all of them.

Compensation mechanics (10 filings)

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
16 Jul 2026 Trerotola Matthew L. Director Award 151
16 Jul 2026 Xing Julie Director Award 151
16 Jul 2026 Glickman Sarah JS Director Award 151
16 Jul 2026 Owens B Craig Director Award 151
16 Jul 2026 Wunderlich Ralf K. Director Award 151
16 Jul 2026 Matthews Candace S. Director Award 226
16 Jul 2026 Marey-Semper Isabel Director Award 151
16 Jul 2026 Kampouri Monnas Giovanna Director Award 151
16 Jul 2026 FOTIADES GEORGE L Director Award 151
15 Jun 2026 Gandhi Aditya CAO Award 2,664

ATR reported financials

SEC EDGAR XBRL

ATR reported revenue of $3.8B for the fiscal year ended 31 Dec 2025. Net income over the same period was $392.8M.

Figure Reported Period
Revenue $3.8B 31 Dec 2025 fiscal year
Net income $392.8M 31 Dec 2025 fiscal year
Diluted EPS $5.89 31 Dec 2025 fiscal year
Total assets $5.1B 31 Mar 2026 at period end
Total equity $2.6B 31 Mar 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 31 Mar 2026

ATR earnings

SEC EDGAR
Date Period EPS Revenue
31 Mar 2026 Q1 2026 $1.12 $983M
31 Dec 2025 FY 2025 $5.89 $3.78B
30 Sep 2025 Q3 2025 $1.92 $961M
30 Jun 2025 Q2 2025 $1.67 $966M

Reported figures & scheduled dates · SEC EDGAR filings

ATR institutional holders

SEC Form 13F

11 of the 45 institutional funds we track reported a ATR position for the quarter ended 31 Mar 2026 — a combined $336.9M; the latest of those filings landed 15 May 2026.

Fund Action Shares Value
AQR Capital Management Added +45.7% shares 1,229,278 $153.7M
D. E. Shaw & Co. Added +144.5% shares 481,958 $60.7M
Balyasny Asset Management Added +213.2% shares 271,589 $34.2M
Millennium Management Held (±25%) +22.7% shares 260,808 $32.9M
Renaissance Technologies Held (±25%) +20.3% shares 172,800 $21.8M
Point72 Asset Management New position 83,527 $10.5M
Man Group Held (±25%) −14.5% shares 66,442 $8.4M
Two Sigma Investments Trimmed −68.7% shares 62,496 $7.9M
Citadel Advisors Trimmed −66.4% shares 28,077 $3.5M
Fisher Asset Management Held (±25%) −1.4% shares 22,757 $2.9M

Source: SEC EDGAR 13F filings

ATR fails-to-deliver

SEC CNS data

On 30 Jun 2026, 10,121 shares of ATR failed to deliver (about $1.3M).

Settlement date Shares failed Notional % of shares out
30 Jun 2026 10,121 $1.3M 0.016%

Source: SEC fails-to-deliver (CNS) data